Primary and secondary autoimmune disorders and hearing loss

AIED should be discussed within the spectrum of "immune-mediated inner ear disease", and therapeutic efficacy may be translated along the spectra. Diagnostic biomarkers must be appraised with caution, and diagnosis still relies on responses to steroids. Steroid sparring agents are efficacious for long-term management, and modern biologics show promise, but further investigation is needed.